Effect of intermediate care on mortality following emergency abdominal surgery. The InCare trial: study protocol, rationale and feasibility of a randomised multicentre trial.

Publikation

Effect of intermediate care on mortality following emergency abdominal surgery. The InCare trial: study protocol, rationale and feasibility of a randomised multicentre trial.

Wissenschaftlicher Artikel/Review - 02.02.2013

Vester-Andersen Morten, Waldau Tina, Wetterslev Jørn, Møller Morten Hylander, Rosenberg Jacob, Jørgensen Lars Nannestad, Gillesberg Inger, Jakobsen Henrik Loft, Hansen Egon Godthåb, Poulsen Lone Musaeus, Skovdal Jan, Søgaard Ellen Kristine, Bestle Morten, Vilandt Jesper, Rosenberg Iben, Berthelsen Rasmus Ehrenfried, Pedersen Jens, Madsen Mogens Rørbæk, Feurstein Thomas, Busse Malene Just, Andersen Johnny D H, Maschmann Christian, Rasmussen Morten, Jessen Christian, Bugge Lasse, Ørding Helle, Møller Ann Merete

Zitation

Vester-Andersen M, Waldau T, Wetterslev J, Møller M, Rosenberg J, Jørgensen L, Gillesberg I, Jakobsen H, Hansen E, Poulsen L, Skovdal J, Søgaard E, Bestle M, Vilandt J, Rosenberg I, Berthelsen R, Pedersen J, Madsen M, Feurstein T, Busse M, Andersen J, Maschmann C, Rasmussen M, Jessen C, Bugge L, Ørding H, Møller A. Effect of intermediate care on mortality following emergency abdominal surgery. The InCare trial: study protocol, rationale and feasibility of a randomised multicentre trial. Trials 2013; 14:37.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Trials 2013; 14

Veröffentlichungsdatum

02.02.2013

eISSN (Online)

1745-6215

Seiten

Kurzbeschreibung/Zielsetzung

Emergency abdominal surgery carries a 15% to 20% short-term mortality rate. Postoperative medical complications are strongly associated with increased mortality. Recent research suggests that timely recognition and effective management of complications may reduce mortality. The aim of the present trial is to evaluate the effect of postoperative intermediate care following emergency major abdominal surgery in high-risk patients.